This is a community-generated profile. If you would like to claim it, please .
Amgen Funding
$175.5M
11 round
Amgen is active in the following markets / industries: biotechnology. The company has secured funding across 1 rounds, totaling in an amount of $175.5M. Their most recent funding was raised on March 12, 2012.
Funding Rounds
U
$175500000Investors of Amgen
Space and deep technology investor. General Partner at Type One Ventures.
Personal investments from family office AJH Investment Holdings.
Josh Lind
My specialty is web development, front-end UX, content management, data flow, and metrics. I believe in design systems and open-source tools.
Founded Crescent Dental Associates, Founded Armion Group, DDS degree from UMAB
Raman Minhas
Medtech enthusiast, working with entrepreneurial ventures; ex-MD; value stock investor
Acquisitions of Amgen
Alantos
Exit
Investments of Amgen
Miragen Therapeutics
Acylin Therapeutics
Epizyme
Ardelyx
Cutting Edge Information
Sutro Biopharma
DecImmune Therapeutics
TetraLogic Pharmaceuticals
Calistoga Pharmaceuticals
Trinity Biosystems
SiteOne
Immatics Biotechnologies
